News Revvity, Inc.

Equities

RVTY

US7140461093

Real-time Estimate Cboe BZX Other stock markets 02:56:21 2024-04-25 pm EDT			5-day change	1st Jan Change
102.4 ^USD	-0.28%		+3.03%	-6.33%

Apr. 24	Revvity Unveils A New Era of Automated Tuberculosis Testing	CI
Apr. 22	Bernstein Adjusts Price Target on Revvity to $125 From $126	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings	09:30am	AQ
Revvity to Present at BofA Securities 2024 Health Care Conference	08:01am	BU
Revvity Unveils a New Era of Automated Tuberculosis Testing	Apr. 24	BU
Revvity Unveils A New Era of Automated Tuberculosis Testing	Apr. 24	CI
Bernstein Adjusts Price Target on Revvity to $125 From $126	Apr. 22	MT
Baird Adjusts Price Target on Revvity to $126 From $123	Apr. 22	MT
Ex-dividend day	Apr. 17	FA
Revvity Signals Software's New Synergy Solution Redefines Collaboration between Pharma and Contract Partners	Apr. 16	AQ
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners	Apr. 15	BU
Revvity To Hold Earnings Call on Monday, April 29, 2024	Apr. 04	BU
Preliminary Injunction Granted to Enforce Revvity s Rights and Cloud Software Group s Obligations Related to Spotfire Software	Apr. 03	AQ
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	Apr. 03	MT
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	Apr. 02	MT
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software	Apr. 02	BU
Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance	Mar. 20	MT
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group	Mar. 20	BU
Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	Mar. 20	CI
Transcript : Revvity, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 09:00 AM	Mar. 20
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication	Mar. 18	BU
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication	Mar. 18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Revvity, Inc.

Equities

RVTY

US7140461093

Summary

Filters